Last reviewed · How we verify
NCT06219993: RKPEVSOKPE
Robot-assisted Modified Kasai Portoenterostomy Versus Open Kasai Portoenterostomy for Biliary Atresia
trial testing robot-assisted modified Kasai portoenterostomy in Biliary Atresia in 60 participants. Status unknown.
30 December 2024
Quick facts
| Lead sponsor | Zunyi Medical College |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 21 December 2023 |
| Primary completion | 30 December 2024 |
| Estimated completion | 30 December 2025 |
| Sites | 2 locations across China |
Drugs / interventions tested
- robot-assisted modified Kasai portoenterostomy
- traditional open Kasai portoenterostomy
Conditions studied
- Biliary Atresia — all drugs for Biliary Atresia →
- Kasai Operation — all drugs for Kasai Operation →
- Robotic Surgery — all drugs for Robotic Surgery →
- Open Surgery — all drugs for Open Surgery →
Sponsor
Zunyi Medical College
Who can join
Under 6 Months, any sex, with Biliary Atresia or Kasai Operation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Open Kasai portoenterostomy (OKPE) is considered the standard treatment procedure for biliary atresia (BA). Robotic-assisted Kasai portoenterostomy (RAKPE) has been utilized to treat BA. However, there were no randomized controlled trials to verify its effectiveness. The objection was to compare the efficacy of Da Vinci robot-assisted with open Kasai portoenterostomy for biliary atresia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06219993
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Biliary Atresia
Currently open trials in the same condition.
- NCT06764082 — Nutritional Intervention for Biliary Atresia · NA · recruiting
- NCT06564740 — Stem Cell Applications in Biliary Atresia Patients · NA · recruiting
- NCT05925309 — Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy · NA · recruiting
- NCT05072626 — High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia · recruiting
- NCT04272515 — Molecular Characterization for Understanding Biliary Atresia · NA · recruiting
Other Zunyi Medical College trials
Trials by the same sponsor.
- NCT07343622 — Robot/Laparoscopic-Assisted Transanal Transection Duhamel Versus Modified Soave Pull-Through for TCA · NA · not yet recruiting
- NCT06674603 — The Trajectory and Influencing Factors of Cognitive Level in ICU Delirium Patients After Transfer Out of the ICU · enrolling by invitation
- NCT06473636 — Mindfulness Training Improves Emotions Among Female Abdominal Cancer Patients · NA · completed
- NCT06283888 — CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention · Phase 4 · recruiting
- NCT06013020 — Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06219993 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zunyi Medical College
- Last refreshed: 23 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06219993.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing